公开(公告)号：EP4292566A3

公开(公告)日：2024-02-28

申请号：EP23184622.1

申请日：2016-12-02

申请人： Edwards Lifesciences Corporation

发明人： COOPER, Alexander H. ,  BIALAS, Michael R. ,  TAYLOR, David M. ,  TYLER, Gregory Scott II ,  PATEL, Darshin S. ,  METCHIK, Asher L. ,  POPP, Michael J. ,  ANDERSON, Amanda K. ,  KOWALSKI, Zachary R. ,  KWAN, Art Z.

IPC分类号： A61F2/24

摘要： In a particular embodiment, the present disclosure provides a prosthetic valve delivery assembly that includes a storage tube. A prosthetic valve having a frame is at least partially disposed within the storage tube. A nose cone is located distally to the valve. A removable tab is disposed between the distal end of the frame and the nose cone. The tab assists in maintaining the position of the nose cone relative to the distal end of the frame.

公开(公告)号：EP4292566A2

公开(公告)日：2023-12-20

申请号：EP23184622.1

申请日：2016-12-02

申请人： Edwards Lifesciences Corporation

发明人： COOPER, Alexander H. ,  BIALAS, Michael R. ,  TAYLOR, David M. ,  TYLER, Gregory Scott II ,  PATEL, Darshin S. ,  METCHIK, Asher L. ,  POPP, Michael J. ,  ANDERSON, Amanda K. ,  KOWALSKI, Zachary R. ,  KWAN, Art Z.

IPC分类号： A61F2/00

摘要： In a particular embodiment, the present disclosure provides a prosthetic valve delivery assembly that includes a storage tube. A prosthetic valve having a frame is at least partially disposed within the storage tube. A nose cone is located distally to the valve. A removable tab is disposed between the distal end of the frame and the nose cone. The tab assists in maintaining the position of the nose cone relative to the distal end of the frame.

公开(公告)号：EP4011331A1

公开(公告)日：2022-06-15

申请号：EP21218181.2

申请日：2018-04-18

申请人： Edwards Lifesciences Corporation

发明人： DELGADO, Sergio ,  DIXON, Eric Robert ,  TAYLOR, David M. ,  METCHIK, Asher L. ,  WINSTON, Matthew ,  SOK, Sam ,  TYLER, Gregory Scott II ,  FRESCHAUF, Lauren R. ,  SIEGEL, Alexander J.

IPC分类号： A61F2/24 ,  A61B17/12 ,  A61B17/00 ,  A61B17/064

摘要： An exemplary implantable prosthetic device has a coaption element and at least one anchor. The coaption element is configured to be positioned within the native heart valve orifice to help fill a space where the native valve is regurgitant and form a more effective seal. The coaption element can have a structure that is impervious to blood and that allows the native leaflets to close around the coaption element during ventricular systole to block blood from flowing from the left or right ventricle back into the left or right atrium, respectively. The coaption element can be connected to leaflets of the native valve by the anchor.

公开(公告)号：EP4011330A1

公开(公告)日：2022-06-15

申请号：EP21218155.6

申请日：2018-04-18

申请人： Edwards Lifesciences Corporation

发明人： DELGADO, Sergio ,  DIXON, Eric Robert ,  TAYLOR, David M. ,  METCHIK, Asher L. ,  WINSTON, Matthew ,  SOK, Sam ,  TYLER, Gregory Scott II ,  FRESCHAUF, Lauren R. ,  SIEGEL, Alexander J.

IPC分类号： A61F2/24 ,  A61B17/12 ,  A61B17/00 ,  A61B17/064

摘要： An exemplary implantable prosthetic device has a coaption element and at least one anchor. The coaption element is configured to be positioned within the native heart valve orifice to help fill a space where the native valve is regurgitant and form a more effective seal. The coaption element can have a structure that is impervious to blood and that allows the native leaflets to close around the coaption element during ventricular systole to block blood from flowing from the left or right ventricle back into the left or right atrium, respectively. The coaption element can be connected to leaflets of the native valve by the anchor.

公开(公告)号：EP3682854A1

公开(公告)日：2020-07-22

申请号：EP20161486.4

申请日：2018-04-18

申请人： Edwards Lifesciences Corporation

发明人： DELGADO, Sergio ,  DIXON, Eric Robert ,  TAYLOR, David M. ,  METCHIK, Asher L. ,  WINSTON, Matthew ,  SOK, Sam ,  TYLER, Gregory Scott II ,  FRESCHAUF, Lauren R. ,  SIEGEL, Alexander J.

IPC分类号： A61F2/24 ,  A61B17/12 ,  A61B17/00 ,  A61B17/064

摘要： An exemplary implantable prosthetic device has a coaption element and at least one anchor. The coaption element is configured to be positioned within the native heart valve orifice to help fill a space where the native valve is regurgitant and form a more effective seal. The coaption element can have a structure that is impervious to blood and that allows the native leaflets to close around the coaption element during ventricular systole to block blood from flowing from the left or right ventricle back into the left or right atrium, respectively. The coaption element can be connected to leaflets of the native valve by the anchor.